Journal article icon

Journal article

Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin

Abstract:

The mechanisms by which truncating mutations in MYBPC3 (encoding cardiac myosin-binding protein C; cMyBPC) or myosin missense mutations cause hypercontractility and poor relaxation in hypertrophic cardiomyopathy (HCM) are incompletely understood. Using genetic and biochemical approaches, we explored how depletion of cMyBPC altered sarcomere function. We demonstrated that stepwise loss of cMyBPC resulted in reciprocal augmentation of myosin contractility. Direct attenuation of myosin function,...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1126/scitranslmed.aat1199

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
RDM
Sub department:
RDM Cardiovascular Medicine
Role:
Author
ORCID:
0000-0003-4671-2030
More by this author
Role:
Author
ORCID:
0000-0003-0225-6424
More by this author
Role:
Author
ORCID:
0000-0002-3287-7849
More by this author
Role:
Author
ORCID:
0000-0002-4257-8623
Expand authors...
Publisher:
American Association for the Advancement of Science Publisher's website
Journal:
Science Translational Nedicine Journal website
Volume:
11
Issue:
476
Article number:
eaat1199
Publication date:
2019-01-23
Acceptance date:
2018-11-30
DOI:
EISSN:
1946-6242
ISSN:
1946-6234
Pmid:
30674652
Source identifiers:
966074
Language:
English
Pubs id:
pubs:966074
UUID:
uuid:5e4660ee-b115-4c4c-a408-0056176b3a4a
Local pid:
pubs:966074
Deposit date:
2019-02-20

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP